R848 and released damage-associated molecular patterns (DAMPs) together activate dendritic cells, enabling T cells to efficiently target and destroy PD-L1-suppressed glioma cells and promoting a strong photothermal immunotherapy (Figure 7A-b). Here, CD274 is linked to glioma.